Current status of radiant whole-body hyperthermia at temperatures >41.5°C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia’

References

• Gautherie M. Whole body hyperthermia: biological and clinical aspects. Berlin, Heidelberg, New York: Springer Verlag, 1991.
   Google Scholar
• Wust P, Riess H, Hildebrandt B, Loffel J, Deja M, Ahlers 0, Kerner T, von Ardenne A, Felix R Feasibility and analysis of thermal parameters for the whole-body-hyperthermia system IRATHERNI-2000. Int J Hyperthermia 2000;16:325–39.
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487–97.
   PubMed Web of Science ®Google Scholar
• Wessalowski R, van Heek-Romanowski R, Issels R, Jurgens FIT, Gobel U. Estimated number of children with cancer eligible for hyperthermia based on population- and treatment-related criteria. hit J Hyperthermia 1999;15:455–66.
   Google Scholar
• Hildebrandt B, Loffel J, Ahlers 0, Wust P, Riess H. Hyperthermia: different methods, different aims, and different problems. Onkologie 1999; 22(5): 420–421.
   Google Scholar
• van Der Zee J. Heating the patient: a promising approach? Ann Oncol 2002;13:1173–84.
   PubMed Web of Science ®Google Scholar
• Robins HI, Dennis WH, Neville AJ, Shecterie LM, Martin PA, Grossmann J, Davis TE, Neville SR, Gillis WK, Rusy BF. A nontoxic system for 41.8°C whole body hyperthermia: results of a phase I study using a radiant heat device. Cancer Res 1985;45: 3937–44.
   Google Scholar
• Steinhausen D, Mayer WK, Ardenne Mv. Evaluation of systemic tolerance of 42.0°C infrared-A whole-body hyperthermia in combination with hyperglycemia and hyperoxemia. Strahlenther Onkol 1994;170: 322–34.
   Google Scholar
• Robins HI, Grossman J, Davis TE, AuBuchon JP, Dennis W. Preclinical trial of a radiant heat device for whole-body hyperthermia using a porcine model. Cancer Res 1983; 43(5): 2018–22.
   Google Scholar
• Robins HI, Woods JP, Schmitt CL, Cohen JD. A new technological approach to radiant heat whole body hyperthermia. Cancer Lett 1994;79:137–43.
   PubMed Web of Science ®Google Scholar
• von Ardenne M. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Strahlenther Onkol 1994;170:581–9.
   PubMedGoogle Scholar
• Strobl B, Janni W, Rjosk D, Rack BK, Kornya L, Bakhshandeh-Bath A, Hegewisch-Becker S, Hildebrandt B, Sommer HL. Chemotherapy with carboplatin/ifosfamide combined with whole body hyperthermia in recurrent ovarian cancer-results of a phase II study (Dolphin-1 -Study). Proc Am Soc Clin Oncol 2002 2002;19:A2523.
   Google Scholar
• Robins HI, Longo WL, Lagoni RK, Neville AJ, Riggs C, Schmitt CL, Hugander A, Young C. A phase I trial of lonidarnine with whole body hyperthermia in advanced cancer. Cancer Res 1988;43:6587–92.
   Google Scholar
• Robins HI, Sielaff KM, Storer B, Hawkins MJ, Borden EC. A phase I trial of human lymphoblastoid intrferon with whole body hyperthermia in advanced cancer. Cancer Res 1989;49:1609–15.
   Google Scholar
• Robins HI, Longo WL, Steeves RA, Cohen JD, Schmitt CL, Neville AJ, O'Keefe S, Lagoni R, Riggs C. Adjunctive therapy (whole body hyperthermia versus lonidarnine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report on two pilot clinical trials and laboratory investigations. Int J Radiat Oncology Biol Phys 1990;18:909–20.
   Google Scholar
• Robins Hl, Cohen JD, Schmitt CL, Tutsch KD, Feierabend C, Arzoomanian RZ, Alberti D, d'Oleire F, Longo W, Heiss C, Rushing D, Love R, Spriggs D. Phase I clinical trial of carboplatin and 41.8°C whole-Body hyperthermia in cancer patients. J Chin Oncol 1993;9: 1787–94.
   Google Scholar
• Robins HI, Rushing D, Kutz M, Tutsch KD, Tiggelaar CL, Paul D, Spriggs D, Kraemer C, Gillis W, Feierabend C, Arzoomanian RZ, Longo W, Alberti D, d'Oliere F, Qu RP, Wilding G, Steart JA. Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients. J Chin Oncol 1997;15: 158–64.
   Google Scholar
• Bakhshandeh A, Bruns I, Traynor A, Robins HI, Eberhardt K, Demedts A, Kaukel E, Koschel G, Gatzemeier U, Kohlmann T, Dalhoff K, Ehlers EM, Gruber Y, Zumschlinge R, Hegewisch-Becker S, Peters SO, Wiedemann GJ. Ifosfamide, carboplatin and etoposide combined with 41.8°C whole body hyperthermia for malignant pleural mesothelioma. Lung Cancer 2003;39: 339–45.
   Google Scholar
• Gruber Y, Hegewisch-Becker S, Bakshandeh-Bath A, Sommer H, Hoffmann R, Hossfeld DK. Whole-body hyperthermia at 41.8°C combined with ifosfamide and carboplatin in relapsed ovarian carcinoma pretreated with a plain-containing regimen. Ann Oncol 2000;11:377P.
   Google Scholar
• Hegewisch-Becker S, Corovic A, Jaeger E, Goekkurt J, Panse J, Nierhaus A, Hossfeld DK. Whole body hyperthermia (WBH, 41.8°C) combined with carboplatin and etoposide in advanced biliary tract cancer. Proc Am Soc Chin Oncol 2003 2003;22:abstr 1247.
   Google Scholar
• Hegewisch-Becker S, Gruber Y, Corovic A, Pichlmeier U, Atanackovic D, Nierhaus A, Hossfeld DK. Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study. Ann Oncol 2002;13: 1197–204.
   Google Scholar
• Hildebrandt B, Wust P, Rick 0, Deja M, Kerner T, Löffel J, Ahlers 0, Dieing A, Weinknecht S, Bechstein WO, Siegert W, Felix R, Riess H. [Whole body hyperthermia in germ cell tumors] . Onkologe 2001;7:324-30, German.
   Google Scholar
• Hildebrandt B, Drager J, Kerner T, Deja M, Loffel J, Stroszczynski C, Ahlers 0, Felix R, Riess H, Wust P. Whole-body hyperthermia in the scope of von Ardenne's 'systemic Cancer Multistep Therapy (sCMT)' combined with chemotherapy in patients with metastatic colorectal cancer-a phase I/II study. Int J Hyperthermia 2004;20:317–33.
   Google Scholar
• Westermann AM, Grosen EA, Katschinski DM, Jager D, Rietbroek R, Schink JC, Tiggelaar CL, Jager E, Zum Vorde Sive Vording P, Neuman A, Knuth A, Van Dijk JD, Wiedemann GJ, Robins HI. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. Eur J Cancer 2001;37:1111–7.
   Google Scholar
• Westermann AM, Wiedemann GJ, Jager E, Jager D, Katschinski DM, Knuth A, Vorde Sive Vording PZ, Van Dijk JD, Finet J, Neumann A, Longo W, Bakhshandeh A, Tiggelaar CL, Gillis W, Bailey H, Peters SO, Robins HI. A systemic hyperthermia oncologic working group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8°C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology 2003; 64:312–21.
   Google Scholar
• Kerner T, Deja M, Gerlach H, Ahlers 0, Löffel J, Wust P, Hildebrandt B, Felix R, Riess H. Whole-body hyperthermia-a secure procedure for patients with various malignancies? Intensive Care Med 1999;25:959–65.
   Google Scholar
• Kerner T, Hildebrandt B, Ahlers 0, Deja M, Riess H, Draeger J, Wust P, Gerlach H. Anaesthesiological experiences with whole body hyperthermia. Int J Hyperthermia 2003;19:1–12.
   PubMed Web of Science ®Google Scholar
• Pereira Arias AM, Wester JP, Blankendaal M, Schilthuis MS, Kuijper EJ, Rademaker BM, Stoutenbeek CP, Rietbroek RC. Multiple organ dysfunction syndrome induced by whole-body hyperthermia and polychemotherapy in a patient with disseminated leiomyosarcoma of the uterus. Intensive Care Med 1999;25:1013–6.
   PubMedGoogle Scholar
• Bakhshandeh A, Bath V, Wiedemann GJ, Longo W, Lerner BM, Tiggelaar CL, Robins HI. Year 2000 guidelines for clinical practice of whole body hyperthermia combined with cytotoxic drugs from the University of Liibeck and the University of Wisconsin. J Oncol Pharm Practice 1999;5: 131–4.
   Google Scholar
• Faithful! NS, Reinhold HS, van der Berg AP, van Rhoon GC, van der Zee J, Wike-Hooley JL. Cardiovascular changes during whole body hyperthermia treatment of advanced malignancy. Eur J Appl Physiol 1984;53: 274–81.
   Google Scholar
• Kerner T, Deja M, Ahlers 0, Hildebrandt B, Dieing A, Riess H, Wust P, Gerlach H. Monitoring arterial blood pressure during whole body hyperthermia. Acta Anaesthesiol Scand 2002;46:561–6.
   Google Scholar
• Berry JM, Michalsen A, Nagle V, Bull JM. The use of esmolol in whole-body hyperthermia: cardiovascular effects. hit J Hyperthermia 1997;13:261–8.
   PubMed Web of Science ®Google Scholar